l l do ti sao a s n ng c nhiu lng hn ph n
At retail, tirzepatide-based medications (Mounjaro/Zepbound at $1,000-1,200/month) are slightly less expensive than semaglutide-based Wegovy ($1,300/month)
These drugs can help you reach your A1C goal, which can prevent diabetes complications like heart and blood vessel disease, nerve or vision damage, and kidney failure
Simple ingredients are more bioavailable, meaning your body can use them more easily
Physiological Reviews, 95(1), 1-46
Longitudinal analyses from the Phase 2 and Phase 3 trials show that the incidence of new-onset nausea and vomiting peaked during the first 4-8 weeks of treatment and then declined substantially during the maintenance phase